Safety and Efficacy of N8 in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 19 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
03 Jul 2017 According to Novo Nordisk media release, data from this trial will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) congress 2017.
06 Dec 2016 Interim results from guardian™2 trial (n=199) and on-demand subtrial (n=19) of turoctocog alfa, presented at the 58th Annual Meeting and Exposition of the American Society of Hematology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com